TrademarkDir
CARNEGIE PHARMA
LIVE

Serial Number

98841106

Owner

Carnegie Pharmaceuticals LLC

Attorney

Marek Krizka

First Use Date

Oct 21, 2025

Filing Date

Nov 7, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CARNEGIE PHARMA Trademark

Serial Number: 98841106 • Registration: 8298019

CARNEGIE PHARMA is a trademark filed by Carnegie Pharmaceuticals LLC on November 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Carnegie Pharmaceuticals LLC (2 trademarks)

600 Delran Pkwy, Unit C
Delran, NJ 08075

Entity Type: 16

Trademark Details

Filing Date

November 7, 2024

Registration Date

June 9, 2026

First Use Anywhere

October 21, 2025

First Use in Commerce

October 21, 2025

Published for Opposition

August 26, 2025

Goods & Services

Dietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical products for the prevention and treatment of cancer; Thyroid and para-thyroid hormone preparations; Vitamin and mineral preparations for medical use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 9, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 18, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 18, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 2, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 2, 2026 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2026 REAP
USE AMENDMENT FILED
Dec 11, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 11, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 13, 2025 CNRT
ASSIGNED TO EXAMINER
May 6, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 5, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2025 NWOS
NEW APPLICATION ENTERED
Nov 7, 2024 NWAP

Related Trademarks

More from this Owner

CARNEGIE PHARMA

CARNEGIE PHARMA